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Abstract
Introduction: Vertebroplasty and Kyphoplasty are two forms of percutaneous vertebral augmentation
(PVA), in which polymethylmethacrylate cement is used to stabilize vertebral compression fractures
(VCF). This study sought to evaluate the relationship between cement volume and clinical outcomes,
including pain reduction, opioid use, and complication rate.
Methods: Retrospective chart review produced 88 patients who received PVA at a tertiary care outpatient
pain clinic. Cement volume, type of PVA, gender, level (thoracic vs lumbar) were collected, as well as
clinical outcomes of numeric pain score (NPS) reduction, opioid percent change (OPC), and
complications. Both pre-procedure and post-procedure (between 2-4 weeks) data were collected.
Results: Sixty-four patients (72.7%) had statistically significant NPS reduction of ≥50% pain (p
Conclusion: Cement volume does not correlate with clinical outcomes of NPS reduction or OPC.
Furthermore, our study reinforced PVA as a beneficial treatment for reducing pain and opioid
consumption in patients with painful VCF.
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Abstract
Introduction: Vertebroplasty and
Kyphoplasty are two forms of percutaneous
vertebral augmentation (PVA), in which
polymethylmethacrylate cement is used to
stabilize vertebral compression fractures
(VCF). This study sought to evaluate the
relationship between cement volume and
clinical outcomes, including pain reduction,
opioid use, and complication rate.
Methods: Retrospective chart review
produced 88 patients who received PVA at a
tertiary care outpatient pain clinic. Cement
volume, type of PVA, gender, level (thoracic
vs lumbar) were collected, as well as clinical
outcomes of numeric pain score (NPS)
reduction, opioid percent change (OPC), and
complications. Both pre-procedure and postprocedure (between two to four weeks) data
were collected.
Results: Sixty-four patients (72.7%) had
       
  
Conclusion: Cement volume does not
correlate with clinical outcomes of NPS
reduction or OPC. Furthermore, our study
          
reducing pain and opioid consumption in
patients with painful VCF.

Introduction
Background: Vertebroplasty and
kyphoplasty are two forms of percutaneous
vertebral augmentation (PVA) used to treat
symptomatic or painful vertebral compression
fractures (VCF).1,2 VCF are associated with
an estimated average hospital stay of 10
days and increased mortality if untreated.3,4
An estimated cost of $1.14 billion dollars
was spent in VCF treatment alone in 2005.5
Symptomatic VCF can be associated with
pain, chronic opioid consumption, and
reduced quality of life.6,7
Cement volume is a commonly discussed
topic in PVA. Increased cement volume
has been suggested to be biomechanically
advantageous for improving individual
vertebral body stiffness, height, and loadsharing among the vertebral bodies.2,8-11
!"#    #    
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promote biomechanical instability due to
asymmetric distributions.12 Also adjacent
vertebral fractures may be associated with
increased cement volume possibly due to
the increased stiffness of the repaired level.13
Besides biomechanics, dose-dependent
increases in cement volume have been
correlated with increased extravasation
into the epidural space, neural foramen,
intervertebral disc space, and vasculature that
could lead to pulmonary embolism.11,14-15
    Sometimes to
avoid adverse events, clinicians minimize
cement volume. A few studies suggest that
increased cement volume does not correlate
with improved clinical outcomes.16-18
However, another study suggests that clinical
improvement does correlate with higher
volumes, although the rate of complications
was higher.19 Additionally, it is important
to mention that some clincians question the
    & '"    *
controlled trials (RCT) using vertebroplasty
+"       
conservative treatment.20,21 However multiple
studies of PVA and a recent kyphoplasty
RCT did demonstrate improved outcomes
of PVA when compared to conservative
treatment.1,22-23 As such, there is a need for
further studies to determine if low cement
volumes would produce the same clinical
    + + #&
Objective: The primary aim of this study is
to evaluate the relationship between cement
volume and clinical outcomes, including pain
reduction, opioid use, and complication rate.
Secondarily, this study sought to provide
+ #        
treatment for painful VCF.

Methods
A retrospective chart review was performed
of all the patients that underwent kyphoplasty
or vertebroplasty by a single experienced
pain management physician at a tertiary care
center between January 2009 and December
2016. The Institutional Review Board
(IRB) approved this study, and waived the
requirement for written informed consent.
This manuscript was written to adhere to
applicable Equator guidelines. Inclusion
criteria consisted of accurate documentation

of numeric pain scores (NPS), exact dosage
of narcotic pain medication being consumed,
surgical complications listed, and cement
volume utilized during procedure. All patients
who met the inclusion criteria were included
in the study.
Patient Population: Percutaneous vertebral
augmentation (PVA) was used to treat
compression fractures in patients with axial
back pain and either an underlying oncologic
malignancy or osteoporosis. PVA would likely
not be performed on compression fractures
with symptoms exceeding one year unless
/:; +" <  &  
"+ + "  
  "
excluded: 80% or greater vertebral height
loss, burst fracture, disc retropulsion greater
+ >?         
compromise secondary to compression
Approach: With the patient under general
anesthesia in the operating room, local
 + "    + @  +
pedicle of each target. Employing biplanar
G + +? + #  +
needles using a bipedicular approach in
all cases. Once a tract was formed into
the vertebral body, she injected cement
material made of polymethylmethacrylate for
vertebroplasty. In the case of kyphoplasty,
 G   "     #
before injecting the cement. The injection was
terminated if leakage was noted in the venous
distribution, or beyond the vertebral endplates.
Outcome Measurements: Multiple outcome
measures were collected in both the preprocedure and post-procedure settings. For
the purpose of this study, pre-procedure was
   +      
the procedure (typically between two weeks
to one day before procedure). Post-procedure
"    +    + 
outpatient visit following the procedure
(typically between two to four weeks after
procedure).
The following data were collected: numeric
pain scores rated on a scale from 0 (no pain)
to a 10 (worst imaginable pain), opioid
dosage in morphine milliequivalents, and
any complications during the procedure,
ranging from any form of extravasation,
infection, wound complications, or mortality.
In addition, data relating to gender, cement
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volume, level (thoracic versus lumbar), and
number of levels augmented were collected.
L  #  G + 
amount used in a bipedicular approach. The
purpose of the study was not to compare
kyphoplasty versus vertebroplasty and the
data were not analyzed separately unless
   + &
Opioid dosages were used to calculate opioid
percent change (OPC). OPC was calculated
by dividing the difference of pre-procedure
and post-procedure opioid dose by the
pre-procedure dose and multiplying by 100
to give a percent. In patients with multiple
opioid medications, doses were converted to
oral morphine milliequivalents prior to the
calculation. This study did not account for
non-opioid analgesic changes.
If a patient had multiple levels augmented
in a procedure, outcomes of NPS and
QL " +    + G +
cumulative result of the entire procedure.
Instead of analyzing the data by individual
level, cement volume was averaged across all
levels in our analysis to produce a single data
point. This approach was selected to prevent
overpowering and skewing of statistics by
those with multilevel PVA.
Statistical Analysis: All t-tests performed
were two-tailed with pairing based on the
data being studied. T-tests were performed to
compare if the mean change of NPS and OPC
"    &  ? U "
utilized to determine if NPS change or OPC
were different across type of vertebral level.
If data were categorical in comparison, such
   #   X # ? 
chi-square test was performed.

Linear regression adjusting for pre-NPS
was performed to determine the relationship
of either OPC or NPS change with cement
volume. Logistic regression was used to
 *   #Z  G   
"+       X
improvement). A professional statistician
assisted with all the statistical analysis.

Results
Demographics: Eighty-eight patients were
included in the study with females accounting
for 53% of the patients. When analyzing the
different types of PVA, 78 patients received
kyphoplasty and 10 patients received
vertebroplasty. For the entire cohort of 88
patients, 47 had PVA at multiple vertebral
levels during the same procedure, with the
following breakdown: 30 at two levels, 15 at
three levels, 2 at four levels. The location of
PVA during each procedure was as follows:
32 lumbar only, 28 thoracic only, and 28 who
received both thoracic and lumbar PVA in the
same procedure. Cement volume used per
vertebral level ranged from 1 to 8mL with 55
  #  #   [>\   >>
patients receiving >3mL.
Change in Numeric Pain Score (NPS): For
the entire cohort of 88 patients, we noted
        +
mean NPS by 4.45% (p<0.0001) from a preprocedure value of 6.92 to a post-procedure
value of 2.37. (Figure 1). This outcome

persisted even when comparing patients with
   _ `{| "+ +   "+
<50% reduction (N=24, p<.001). In contrast,
"          
(p=0.26) for decrease in the NPS between
lumbar (mean reduction of 4.16) versus
thoracic (mean reduction of 5.06) levels of
& ?   +   G  "+
an equivalent percentage of females (72.34%)
   ~>&~|    
reduction in NPS (p=0.93).
Linear regression using pre-NPS as the
covariate showed that cement volume did
 +#        + + 
in NPS (p=0.173) as demonstrated in Figure
2. When analyzed as a categorical variable,
there was no statistical difference in NPS
reduction between patients who received
  #  [>   
4.16) versus those who received >3ml (mean
reduction of 4.94, p =0.25).
Opioid Reduction: Seventy-two patients
who were on opioids pre-procedure were
included in this analysis. We noted a mean
OPC reduction of 48%. A statistically
      X&| " 
between patients with opioid reduction (n=63)
when compared to patients (n=9) with no
improvement in opioid consumption. (Figure
3). There was no difference (p=0.71) in opioid
reduction between lumbar (n= 25, mean
reduction= 44%) versus thoracic (n= 22, mean
reduction= 49%) levels of PVA.
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Figure 1. Average pain improvement. The mean
Numeric Pain Score (NPS) pre-procedure (6.82)
        
intervals displayed for a total of 88 patients. A
mean reduction of 4.45 was present which was
      !!!"
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Figure 2. Difference in pain by cement volume and pre-treatment score. Scatter plot with linear
regression analysis using pre NPS as the covariate shows the effect of cement volume on NPS
change. Three regression lines are drawn with various pre-treatment NPS scores (1,5,9) that failed
      #!"$%#!&"'   *  +    / :   
difference scores, conceptually the left axis refers to the regression lines and the right vertical refers to
the points plotted in the interior. Abbreviations: NPS=Numeric Pain Score
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We then analyzed if there was an effect of
cement volume on opioid dosage reduction.
Linear regression with two independent
variables (adjusted for pre-NPS covariate
and relationship of opioid decrease with
cement volume) showed no relationship of
opioid decrease with cement volume (p=.299)
(Figure 4).
Complications/Adverse Reactions: A
total of nine complications (four intradiscal
extravasations, three pulmonary vessel
cement uptakes, and two other uncomplicated
extravasations) were reported for a total
complication rate of 10.2%. However,
it should be noted that all complications
were asymptomatic with the exception
of one patient treated for symptomatic
dyspnea after pulmonary vessel cement
uptake. The other complications were noted
incidentally on follow up imaging or during
G&    +   " 
to experience more than one complication.
A complete breakdown of complications by
  # [ > # >|    
procedure (kyphoplasty vs vertebroplasty) can
be found in Table 1.

Discussion
Our retrospective study of 88 patients who
#      &
        
NPS improvement, with 72.7% of them

+#     + 
follow up appointment. Importantly, previous
opioid consumers were able to decrease their
opioid consumption by 48%, which was
    & Q   
  "+ +    + 
studies.22,24 Our analysis also showed that
neither gender nor vertebral level (thoracic vs.
| +    G    
outcomes.
Our study also demonstrated that cement
volume did not have any statistically
          ?
"++       #
studies.16,17 Although not statistically
   ? + :2 in both regression graphs
(Figures 2 & 4) showed a positive correlation
between cement volume and both NPS and
opioid reduction. It is likely that a study
with a larger sample size could potentially
         
volume.
We noted a cement leakage rate of 10.2%
"++  + " + +  
reported by Zhan et al.14 In their metaanalysis, Zhan et al noted a much higher
cement leakage rate of 54.7% (vertebroplasty)
and 18.4% (kyphoplasty) respectively. For
  "     [>\  
a relatively low volume and anything greater
to be high volume. It was interesting that
pulmonary vessel cement uptake occurred

exclusively in high volume while intradiscal
extravasation occurred exclusively in low
volume. Both complications did occur
predominantly in patients with kyphoplasty,
which was unexpected. Intraoperative venous
uptake of cement can go undetected, which
can lead to injecting higher volumes of
cement. In contrast, intradiscal extravasations
are more easily detected intraoperatively,
which leads to termination of the procedure at
a lower volume of cement.
This study as several limitations. We did
  *      G # 
cement but arbitrarily determined a cut-off
point of 3ml. It is likely that a lower volume
of cement may have provided a therapeutic
    "& /   +" +
2cc of polymethylmethacrylate improved
strength and stiffness in thoracic compression
fractures by 69% and 80% respectively.9
Thus based on this study, achieving 100%
restoration is likely not needed to receive
     &  +?  
study we did not use volumes lower than
1ml due to impracticality. The study does not
include follow up beyond four weeks. We
also included patients with a mix of benign
and malignant diagnoses, which could have
an effect on the measured outcomes. Finally,
due to the small number of patients, we were
not able to perform separate analysis for
patients that underwent vertebroplasty and
kyphoplasty.

Number of Patients

80
63
60
40
20
9
0
No

Yes

Was Opioid Reduction Present
Figure 3. Reduction in opioids after treatment.
Graphical display of patients who demonstrated
any opioid reduction versus those with no
improvement in opioid consumption in a
categorical fashion. Seventy-two patients who
were on opioids pre-procedure were included
in this analysis. We noted a mean opioid
percent change of 48%. Following treatment
with percutaneous vertebral augmentation,
      /< :   
experienced opioid reduction (n=63) when
compared to patients (n=9) with no reduction in
opioid consumption (p<0.0001).

20 Review

Figure 4. Opioid decrease by cement volume and pre-treatment score. Scatter plot displaying linear
regression analysis with two independent variables (adjusted for pre-NPS covariate and relationship
of opioid decrease with cement volume). Three regression lines are drawn with various pre-treatment
?@I  "KK  :    #%#!!L  : + :    
pre-treatment lines and the right axis refers to the plotted points. Positive opioid decrease implies a
reduction, while negative infers opioid increase. Abbreviations: NPS=Numeric Pain Score.
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In summary, the results of our study
       
vertebroplasty and kyphoplasty with a
reduction in NPS and opioid consumption.
Further studies with a larger number of
     #   & 

Table 1.
The total number of complications by type of complication. Each type of complication is then further
separated based on type of procedure and cement volume injected.
Type Of Complication

https://doi.org/10.32873/unmc.dc.gmerj.2.1.004
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